CG
VIR icon

Cutler Group’s Vir Biotechnology VIR Stock Holding History

Cutler Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-600
Closed -$8K – 5573
2022
Q2 		$8K Sell
600
-9,800
-94% -$229K ﹤0.01% 3405
2022
Q1 		$22K Buy
10,400
+2,000
+24% +$59.3K ﹤0.01% 2981
2021
Q4 		$29K Buy
+8,400
New +$329K ﹤0.01% 2840
2021
Q1 		– Sell
-2,000
Closed -$14K – 6347
2020
Q4 		$14K Sell
2,000
-1,100
-35% -$35.8K ﹤0.01% 2951
2020
Q3 		$32K Buy
3,100
+1,200
+63% +$51.7K ﹤0.01% 2114
2020
Q2 		$5K Buy
+1,900
New +$63.8K ﹤0.01% 3359

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return